Abliva AB NEVPF:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 03/04/24 EDT
0.01UNCH (UNCH)
52 week range
0.00 - 0.02
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.01
  • 52 Week High0.02
  • 52 Week High Date01/05/24
  • 52 Week Low0.00
  • 52 Week Low Date04/04/23

Key Stats

  • Market Cap14.89M
  • Shares Out1,056.3M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.01
  • 52 Week High0.02
  • 52 Week High Date01/05/24
  • 52 Week Low0.00
  • 52 Week Low Date04/04/23
  • Market Cap14.89M
  • Shares Out1,056.3M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.01
  • P/E (TTM)-1.12
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Abliva AB

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Abliva AB is a Sweden-based company involved in pharmaceutical industry. The Company focuses on the development of novel treatments for primary mitochondrial diseases.
David Laskow-Pooley
Independent Chairman of the Board
Ellen Donnelly
Chief Executive Officer
Address
Medicon Village, Scheeletorget 1
Lund
223 81
Sweden